Home > Insider Trading > Filing (0001209191-16-130106)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Paratek Pharmaceuticals Inc.	PRTK	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403748	Omega Fund Iii, L.p.	1 Royal Plaza, Royal Avenue St. Peter Port Guernsey, Channel Islands X0 GY1 2HL		No	No	Yes	No
1528382	Omega Fund Iv, L.p.	1 Royal Plaza, Royal Avenue St. Peter Port Guernsey, Channel Islands X0 uk		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-27	76,923	$13.00	1,187,365	No	4	P	Direct
Common Stock	Acquisiton	2016-06-27	384,615	$13.00	779,802	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The Reporting Persons are part of a "group" as defined in Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended (which group also includes K/S Danish BioVenture ("Danish BV") and Danish BioVenture General Partner ApS, whose securities are beneficially owned by Clessidra, LLC. This group beneficially owns, in the aggregate, 2,600,410 shares of common stock of the issuer and warrants to purchase an additional6,412 shares of common stock of the issuer.
The reported securities are held in the name of Omega Fund III, L.P. ("Omega III"). The Reporting Person disclaims beneficial ownership of these securities,except to the extent of its pecuniary interest therein.
The reported securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person disclaims beneficial ownership of these securities,except to the extent of its pecuniary interest therein.